Gerald L. Messerschmidt

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Worldwide Clinical Trials LLC provides drug development services to the pharmaceutical and biotechnology industries. The firm offers therapeutic solutions in the areas of neuroscience, cardiovascular, inflammation, oncology and rare disease. The company was founded by Neal R. Cutler and Angelico Carta in 1986 and is headquartered in Morrisville, NC.

Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA.

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA

C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ.

DNX Corp. provides pre-clinical drug development services to the pharmaceutical and biotechnology industry. The private company is based in Princeton, NJ and has subsidiaries in Switzerland and France. The company was founded by John K. Clarke, Steven H. Holtzman.